Paper33666232
Partitioning metabolism between growth and product synthesis for coordinated production of wax esters in Acinetobacter baylyi ADP1.
Santala S and 3 others. Biotechnol Bioeng, 2021. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Partitioning metabolism between growth and product synthesis for coordinated production of wax esters in Acinetobacter baylyi ADP1. Papers, record 33666232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33666232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acinetobacter | Major topic |
| Esters | Major topic |
| Metabolic Engineering | Major topic |
| Waxes | Major topic |
| Biomass | |
| Bioreactors | |
| Culture Media | |
| Gluconates | |
| Industrial Microbiology |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41697724 | Mixed Waste Streams for Bioproduction: Exploring Bacterial Wax Ester Production in Nitrogen-Rich Acidogenic Fermentate. | Microb Biotechnol | 2026 | https://conductscience.org/library/papers/41697724 | PubMed |
| 40864971 | Rewiring Aromatic Compound Consumption: Chromosomal Amplification and Evolution of a Foreign Pathway in Acinetobacter baylyi ADP1. | ACS Synth Biol | 2025 | https://conductscience.org/library/papers/40864971 | PubMed |
| 40827875 | Genome evolution of Acinetobacter baylyi ADP1 during laboratory domestication: acquired mutations impact competence and metabolism. | Appl Environ Microbiol | 2025 | https://conductscience.org/library/papers/40827875 | PubMed |
| 39555486 | Metabolic engineering of Acinetobacter baylyi ADP1 for naringenin production. | Metab Eng Commun | 2024 | https://conductscience.org/library/papers/39555486 | PubMed |
| 38711153 | Enhanced upgrading of lignocellulosic substrates by coculture of Saccharomyces cerevisiae and Acinetobacter baylyi ADP1. | Biotechnol Biofuels Bioprod | 2024 | https://conductscience.org/library/papers/38711153 | PubMed |
| 36532595 | Engineering the glyoxylate cycle for chemical bioproduction. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/36532595 | PubMed |
| 36005297 | Engineering cell morphology by CRISPR interference in Acinetobacter baylyi ADP1. | Microb Biotechnol | 2022 | https://conductscience.org/library/papers/36005297 | PubMed |
| 35768954 | Genetic characterization of the cyclohexane carboxylate degradation pathway in the denitrifying bacterium Aromatoleum sp. CIB. | Environ Microbiol | 2022 | https://conductscience.org/library/papers/35768954 | PubMed |
| 34788063 | Characterization of Highly Ferulate-Tolerant Acinetobacter baylyi ADP1 Isolates by a Rapid Reverse Engineering Method. | Appl Environ Microbiol | 2022 | https://conductscience.org/library/papers/34788063 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33666232
GET https://conductscience.org/api/papers/v1/33666232/authors